BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer
Date
2022-09-16
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Abstract
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Diskin, Brian, Salma Adam, Gustavo Sanchez Soto, Miguel Liria, Berk Aykut, Belen Sundberg, Eric Li, Joshua Leinwand, et al. (2022). BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Oncogene, 41(38). pp. 4349–4360. 10.1038/s41388-022-02425-4 Retrieved from https://hdl.handle.net/10161/30182.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Berk Aykut
College/University: Ruprecht Karl University of Heidelberg
Medical School: Ruprecht Karl University of Heidelberg
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.